Form 8-K NanoString Technologies For: Aug 05

Go back to Form 8-K NanoString Technologies For: Aug 05

Nanostring Tech (NSTG) Tops Q2 EPS by 7c; Receives Approval in Australia for Prosigna Assay

August 5, 2014 4:52 PM EDT

Nanostring Tech (NASDAQ: NSTG) reported Q2 EPS of ($0.58), $0.07 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $10.9 million versus the consensus estimate of $10.2 million.

The company also announced that it has received market approval from the Australian Therapeutic Goods... More